Stenocare A/S (CPH:STENO)

Market Cap	49.03M +568.6%
Revenue (ttm)	9.24M +397.1%
Net Income	-855.22K
EPS	-0.02
Shares Out	43.20M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	152,211
Open	1.130
Previous Close	1.135
Day's Range	1.080 - 1.155
52-Week Range	0.401 - 2.800
Beta	0.50
Analysts	n/a
Price Target	n/a
Earnings Date	Aug 20, 2026

About Stenocare

Stenocare A/S cultivates, produces, imports, distributes, and sells prescription-based medical cannabis products to patients in Denmark and internationally. It offers medical cannabis oil products, including THC, THC/CBD, and CBD, as well as CBD100 oil products. The company was incorporated in 2017 and is based in Randers, Denmark.

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 2017
• Employees: 4
• Stock Exchange: Copenhagen Stock Exchange
• Ticker Symbol: STENO

Financial Performance

In 2025, Stenocare's revenue was 7.02 million, an increase of 214.56% compared to the previous year's 2.23 million. Losses were -2.39 million, -93.07% less than in 2024.